$28 Million Xarelto Jury Award Overturned
A state judge in Pennsylvania has overturned a $27.8 million jury award to a woman who suffered severe gastrointestinal bleeding after taking the blood-thinning drug Xarelto.
Jury Awards $28 Million in Xarelto Bleeding Injury Lawsuit
A jury in Philadelphia has slammed Bayer and Johnson & Johnson with a $28 million verdict in favor of plaintiffs who were injured by bleeding after taking the blood-thinning drug Xarelto.
Xarelto Trials Begin April 24 Unless Lawyers Reach Settlement
The first trial out of 17,000 Xarelto lawsuits will begin on April 24 unless lawyers negotiate a settlement. Two years ago, a similar litigation involving Pradaxa ended with a $162 million settlement just before trials began, for an average payout...
100,000 Reasons Why Johnson & Johnson Wants to Forget 2016
Johnson & Johnson was hit with 6 out of 7 of the biggest injury verdicts of 2016. The company is accused of putting profits above public safety in 100,000 lawsuits over baby powder, vaginal mesh, hip implants, Risperdal, Xarelto, and...
Janssen Faces Over 15,000 Xarelto Bleeding Lawsuits
Over 15,000 lawsuits have been filed by people who had severe, uncontrollable bleeding after taking the blood-thinning drug Xarelto.
FDA Reaffirms Safety of Xarelto in A-Fib Patients
After a comprehensive review, the U.S. Food & Drug Administration (FDA) has concluded that Xarelto (generic: rivaroxaban) is a safe and effective alternative to warfarin in patients with atrial fibrillation (a-fib).
Cases Picked for Xarelto Trials in 2017
A federal judge overseeing 7,200 Xarelto lawsuits has picked a case involving a man who experienced severe gastrointestinal bleeding for the first "bellwether" trial in February 2017.